Q3 2023
Released Nov 8, 2023, after the close
10-Q filed Nov 8, 2023, 39 days after period end · 0001493152-23-039890
Q3 2023 · 10-Q
Revenue$3.74M$3.74M +55.3% vs Q3 2022+5.6% vs Q2 2023
Net Income-$182.00K-$182.00K N/M vs Q3 2022N/M vs Q2 2023
EPS Diluted-$0.02-$0.02 N/M vs Q3 2022N/M vs Q2 2023
Gross Profit$2,194,000+187.9%
Operating Income-$203,000N/M
Operating Cash Flowderived$562,000N/M
Margins · derived
Gross margin58.6%+27.0 pt vs Q3 2022
Operating margin-5.4%+47.8 pt vs Q3 2022
Net margin-4.9%+129.3 pt vs Q3 2022
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $3.74M | $2.41M | $2.58M | $2.12M |
| Net Income | -$182.00K | -$3.23M | -$1.22M | -$1.01M |
| EPS Diluted | -$0.02 | -$0.31 | -$0.12 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR